The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer Article

Passiglia, Francesco, Caparica, Rafael, Giovannetti, Elisa et al. (2016). The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer . 25(4), 385-392. 10.1517/13543784.2016.1152261

International Collaboration

cited authors

  • Passiglia, Francesco; Caparica, Rafael; Giovannetti, Elisa; Giallombardo, Marco; Listi, Angela; Diana, Patrizia; Cirrincione, Girolamo; Caglevic, Christian; Raez, Luis E; Russo, Antonio; Rolfo, Christian

fiu authors

publication date

  • April 2, 2016

keywords

  • ADVANCED SOLID TUMORS
  • ALK INHIBITOR
  • ENTRECTINIB
  • ETV6-NTRK3 GENE FUSION
  • EXPRESSION
  • Life Sciences & Biomedicine
  • NTRK-inhibitors
  • NTRK1/2/3
  • ORAL PAN-TRK
  • Pharmacology & Pharmacy
  • REARRANGEMENTS
  • RECEPTOR
  • SENSITIVITY
  • Science & Technology
  • TARGETED THERAPY
  • TrkA/B/C
  • lung cancer
  • targeted therapy

Digital Object Identifier (DOI)

start page

  • 385

end page

  • 392

volume

  • 25

issue

  • 4